Francoise Goirand

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Harmonizing Patient Education on Immunosuppressive Therapy in Solid Organ Transplantation: A National French Initiative.

Harmonizing Patient Education on Immunosuppressive Therapy in Solid Organ Transplantation: A National French Initiative.

Journal: Transplantation

Published: February 12, 2026

Targeting the TGF-β pathway in pulmonary fibrosis: Is it still a relevant strategy?

Targeting the TGF-β pathway in pulmonary fibrosis: Is it still a relevant strategy?

Journal: Revue des maladies respiratoires

Published: March 01, 2025

Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies.

Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies.

Journal: Theranostics

Published: November 04, 2024

Biological pharmacology: A white paper

Biological pharmacology: A white paper

Journal: Therapie

Published: August 08, 2024

Plasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration.

Plasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration.

Journal: Cancer chemotherapy and pharmacology

Published: July 25, 2024

Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.

Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.

Journal: Clinical pharmacokinetics

Published: June 13, 2024

A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.

A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.

Journal: Therapie

Published: March 14, 2024

An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis.

An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis.

Journal: British journal of pharmacology

Published: December 21, 2023

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis.

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis.

Journal: Thorax

Published: November 06, 2023

HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling.

HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 28, 2022

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases.

Journal: International journal of molecular sciences

Published: July 30, 2021

[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach.

[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 10, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026